Glass Pharms
Articles by
Access Brand Launched
EcoCann Access brand launch Glass Pharms are happy to announce the launch of its new access brand for UK Medical Cannabis which is both economical and eco-friendly.
Mamedica + Glass Pharms
Mamedica + Glass Pharms Glass Pharms has announced a new partnership with Mamedica, one of the country’s leading private medical cannabis clinics. Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use).
Interview with BWB
Interview on podcasts.apple.com Our CEO meets Andy Oury from Business without Bullshit to discuss medical cannabis in the UK. Available on Apple Podcasts,
Warwickshire Police Education Day
Warwickshire Police Education Day 15/05/2025 We were delighted to welcome the drug expert team from Warwickshire Police for an education day onsite at Glass Pharms in collaboration with Releaf Clinic. This was part of our ongoing process of mutual education and collaboration with law enforcement."This was an excellent day of CPD for our drug expert witness cadre. By far, this was the most informative CPD I’ve had around medical cannabis and the knowledge and passion from James and the team was unbelievable! Every single expert that came away from the inputs and tour were blown away with the hospitality and knowledge....
Our tins showcased by Made in Britain®
Made in Britain feature
Video Blog with CEOs of Releaf & Glass Pharms
CEO of Releaf, Tim Kirby, and James Duckenfield, CEO of Glass Pharms. Tim & James discuss the challenges and progress within the UK's medical cannabis industry since its legalisation in 2018, highlighting the previous stagnation due to various factors including inconsistent supply chains and a lack of a healthcare-focused approach. The discussion emphasises the importance of quality, consistency, and patient outcomes, showcasing how their collaboration aims to provide reliable medical cannabis to patients. They also touch upon the regulatory landscape, the need for better education for doctors, and the potential for significant growth in the UK market by addressing unmet...